Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of vecuronium and pipecuronium on neutrophil CD11b expression in isolated human venous blood
ChiCTR1900024761Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Jul 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vecuronium and pipecuronium (4 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: Average optical density intensity of CD11b expression. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
vecuroniumpipecuronium
Beyond the preview
Go deeper on ChiCTR1900024761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024761.